相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Geoffrey Burnstock, our friend and magister: the diadenosine polyphosphate connection
Maria-Teresa Miras-Portugal et al.
PURINERGIC SIGNALLING (2021)
Real-time measurement of adenosine and ATP release in the central nervous system
Nicholas Dale
PURINERGIC SIGNALLING (2021)
P2X7 is a cytotoxic receptor horizontal ellipsis .maybe not: implications for cancer
Francesco Di Virgilio
PURINERGIC SIGNALLING (2021)
Nociceptive signaling of P2X receptors in chronic pain states
Kazuhide Inoue
PURINERGIC SIGNALLING (2021)
Geoffery Burnstock's influence on the evolution of P2X3 receptor pharmacology
Michael F. Jarvis
PURINERGIC SIGNALLING (2021)
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Peter Illes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Purinergic signalling in spinal pain processing
Theresa H. Tam et al.
PURINERGIC SIGNALLING (2021)
Update of P2Y Receptor Pharmacology: IUPHAR Review:27
Kenneth A. Jacobson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Romain Lara et al.
FRONTIERS IN PHARMACOLOGY (2020)
Gefapixant in two randomised dose-escalation studies in chronic cough
Jaclyn A. Smith et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Characterisation of P2Y2 receptors in human vascular endothelial cells using AR-C118925XX, a competitive and selective P2Y2 antagonist
Markie O. Muoboghare et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
GPCR homo-oligomerization
Graeme Milligan et al.
CURRENT OPINION IN CELL BIOLOGY (2019)
BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration
Denis Garceau et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2019)
Molecular mechanisms of human P2X3 receptor channel activation and modulation by divalent cation bound ATP
Mufeng Li et al.
ELIFE (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization
Alanna E. McCarthy et al.
CELL (2019)
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications
Gabriella Marucci et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
DT-0111: a novel drug-candidate for the treatment of COPD and chronic cough
Amir Pelleg et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding
S. J. Mundell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Geoffrey Burnstock et al.
PURINERGIC SIGNALLING (2018)
Tools and drugs for uracil nucleotide-activated P2Y receptors
Muhammad Rafehi et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Druggable negative allosteric site of P2X3 receptors
Jin Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Protease-activated receptor-4 and purinergic receptor P2Y12 dimerize, co-internalize, and activate Akt signaling via endosomal recruitment of β-arrestin
Thomas H. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Structural insights into the competitive inhibition of the ATP-gated P2X receptor channel
Go Kasuya et al.
NATURE COMMUNICATIONS (2017)
Structural insights into the nucleotide base specificity of P2X receptors
Go Kasuya et al.
SCIENTIFIC REPORTS (2017)
A phase I clinical trial demonstrates that nfP2X7-targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma
S. M. Gilbert et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
X-ray structures define human P2X3 receptor gating cycle and antagonist action
Steven E. Mansoor et al.
NATURE (2016)
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2016)
Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation
Welbeck Danquah et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Structural Insights into Divalent Cation Modulations of ATP-Gated P2X Receptor Channels
Go Kasuya et al.
CELL REPORTS (2016)
Structural basis for subtype-specific inhibition of the P2X7 receptor
Akira Karasawa et al.
ELIFE (2016)
Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension
Akiyuki Nishimura et al.
SCIENCE SIGNALING (2016)
Functional and molecular evidence for heteromeric association of P2Y1 receptor with P2Y2 and P2Y4 receptors in mouse granulocytes
Antonio Carlos Ribeiro-Filho et al.
BMC PHARMACOLOGY & TOXICOLOGY (2016)
ATP as a cotransmitter in the autonomic nervous system
Charles Kennedy
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2015)
Two disparate ligand-binding sites in the human P2Y1 receptor
Dandan Zhang et al.
NATURE (2015)
Alanine-(87)-threonine polymorphism impairs signaling and internalization of the human P2Y11 receptor, when co-expressed with the P2Y1 receptor
Michael Haas et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Agonist-bound structure of the human P2Y12 receptor
Jin Zhang et al.
NATURE (2014)
Structure of the human P2Y12 receptor in complex with an antithrombotic drug
Kaihua Zhang et al.
NATURE (2014)
The Physical Association of the P2Y12 Receptor with PAR4 Regulates Arrestin-Mediated Akt Activation
Aasma Khan et al.
MOLECULAR PHARMACOLOGY (2014)
G Protein-Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Sergi Ferre et al.
PHARMACOLOGICAL REVIEWS (2014)
P2X and P2Y nucleotide receptors as targets in cardiovascular disease
Charles Kennedy et al.
FUTURE MEDICINAL CHEMISTRY (2013)
A Selective High-Affinity Antagonist of the P2Y14 Receptor Inhibits UDP-Glucose-Stimulated Chemotaxis of Human Neutrophils
Matthew O. Barrett et al.
MOLECULAR PHARMACOLOGY (2013)
Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors
W. Noerenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Molecular mechanism of ATP binding and ion channel activation in P2X receptors
Motoyuki Hattori et al.
NATURE (2012)
Cellular function and molecular structure of ecto-nucleotidases
Herbert Zimmermann et al.
PURINERGIC SIGNALLING (2012)
NF546 [4,4 '-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha '-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y(11) Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells
Sabine Meis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Two-pore potassium ion channels are inhibited by both G(q/11)- and G(i)-coupled P2Y receptors
Sony Shakya Shrestha et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
A membrane network of receptors and enzymes for adenine nucleotides and nucleosides
Klaus Schicker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Studies on the role of the extracellular cysteines and oligomeric structures of the P2Y(12) receptor when interacting with antagonists
Z. Ding et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Pore architecture and ion sites in acid-sensing ion channels and P2X receptors
Eric B. Gonzales et al.
NATURE (2009)
Crystal structure of the ATP-gated P2X4 ion channel in the closed state
Toshimitsu Kawate et al.
NATURE (2009)
Diastereoselectivity of the P2Y11 nucleotide receptor: mutational analysis
D. Ecke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Constitutive and agonist-induced dimerizations of the P2Y1 receptor -: Relationship to internalization and scaffolding
Roy C. Y. Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor
I. Algaier et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Specificity of olfactory receptor interactions with other G protein-coupled receptors
Cristina F. Bush et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems
Nadia D'Ambrosi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Identification of atropine- and P2X1 receptor antagonist-resistant, neurogenic contractions of the urinary bladder
Charles Kennedy et al.
JOURNAL OF NEUROSCIENCE (2007)
Regulation of pharmacology by hetero-oligomerization between A1 adenosine receptor and P2Y2 receptor
Tokiko Suzuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts
Pierre Savi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy
Maria P. Abbracchio et al.
PHARMACOLOGICAL REVIEWS (2006)
Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor
YC Kim et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Heteromeric association creates a P2Y-like adenosine receptor
K Yoshioka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)